Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis
Status:
Completed
Trial end date:
2013-08-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of short-term treatment with fluocinonide
cream 0.1% (Vanos®) in the treatment of atopic dermatitis (AD).
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest University Wake Forest University Health Sciences need to be deleted